Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

BUY
$9.02 - $10.29 $559 - $637
62 New
62 $0
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $39 - $61
-4 Closed
0 $0
Q4 2021

Feb 02, 2022

SELL
$12.09 - $14.68 $169 - $205
-14 Reduced 77.78%
4 $0
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $238 - $272
18 New
18 $0
Q2 2021

Aug 13, 2021

SELL
$12.97 - $16.15 $233 - $290
-18 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$13.59 - $18.54 $190 - $259
-14 Reduced 43.75%
18 $0
Q4 2020

Mar 11, 2021

BUY
$14.3 - $18.74 $443 - $580
31 Added 3100.0%
32 $1,000
Q4 2020

Mar 04, 2021

BUY
$14.3 - $18.74 $14 - $18
1 New
1 $32,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Robbins Farley LLC Portfolio

Follow Robbins Farley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robbins Farley LLC with notifications on news.